25
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Effects of Omeprazole and Lansoprazole on 24-Hour Intragastric pH in Helicobacter pylori-Positive Volunteers

, , &
Pages 1065-1069 | Received 27 Jan 1994, Accepted 12 Apr 1994, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kenneth L Roland & Karen E Brenneman. (2013) Salmonella as a vaccine delivery vehicle. Expert Review of Vaccines 12:9, pages 1033-1045.
Read now

Articles from other publishers (28)

Forough Saki, Mesbah Shams, Sanaz Dastghaib & Farhad Koohpeyma. (2023) Pantoprazole-Induced Bone Loss through Gastrin Secretion: A Stereological Study. BioMed Research International 2023, pages 1-11.
Crossref
Sae-Ryung Kang, Dinh-Huy Nguyen, Su Woong Yoo & Jung-Joon Min. (2022) Bacteria and bacterial derivatives as delivery carriers for immunotherapy. Advanced Drug Delivery Reviews 181, pages 114085.
Crossref
Kenneth L. Roland, Qingke Kong & Yanlong Jiang. 2020. Mucosal Vaccines. Mucosal Vaccines 383 399 .
Marcello Maggio, Fulvio Lauretani, Gian Paolo Ceda, Francesca De Vita, Giuliana Bondi, Andrea Corsonello, Chiara Cattabiani, Fabrizia Lattanzio, Carmelinda Ruggiero, Antonio Nouvenne, Tiziana Meschi, Stefania Bandinelli & Luigi Ferrucci. (2013) Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals. Bone 57:2, pages 437-442.
Crossref
A. Parodi, E.C. Lauritano, G. Nardone, L. Fontana, V. Savarino & A. Gasbarrini. (2009) Small intestinal bacterial overgrowth. Digestive and Liver Disease Supplements 3:2, pages 44-49.
Crossref
Julia Kirchheiner, Silke Glatt, Uwe Fuhr, Ulrich Klotz, Ingolf Meineke, Thomas Seufferlein & Jürgen Brockmöller. (2008) Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH. European Journal of Clinical Pharmacology 65:1, pages 19-31.
Crossref
Julija Armalytė, Vaida Šeputienė, Öjar Melefors & Edita Sužiedėlienė. (2008) An Escherichia coli asr mutant has decreased fitness during colonization in a mouse model. Research in Microbiology 159:6, pages 486-493.
Crossref
Mary Beth O’Connell, Denyse M. Madden, Anne M. Murray, Robert P. Heaney & Lawrence J. Kerzner. (2005) Effects of proton pump inhibitors on calcium carbonate absorption in women: A randomized crossover trial. The American Journal of Medicine 118:7, pages 778-781.
Crossref
Xavier Calvet & Fernando Gomoll??n. (2005) What is Potent Acid Inhibition, and How Can it be Achieved?. Drugs 65:Supplement 1, pages 13???23.
Crossref
Einar Husebye. (2005) The Pathogenesis of Gastrointestinal Bacterial Overgrowth. Chemotherapy 51:1, pages 1-22.
Crossref
David Y Graham. (2003) The Changing Epidemiology of Gerd: Geography and Helicobacter Pylori. American Journal of Gastroenterology 98:7, pages 1462-1470.
Crossref
Jin Il Kim, Soo‐Heon Park, Jae Kwang Kim, In Sik Chung, Kyu Won Chung & Hee Sik Sun. (2002) The Effects of Nocturnal Acid Breakthrough on Helicobacter pylori Eradication . Helicobacter 7:6, pages 331-336.
Crossref
P. O. Katz, S. Xue & D. O. Castell. (2002) Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg. Alimentary Pharmacology & Therapeutics 15:5, pages 647-652.
Crossref
R. Fass, U. Murthy, C. W. Hayden, I. B. Malagon, G. Pulliam, C. Wendel & T. O. G. Kovacs. (2002) Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro‐oesophageal reflux disease (GERD) who are resistant to conventional‐dose lansoprazole therapy—a prospective, randomized, multi‐centre study. Alimentary Pharmacology & Therapeutics 14:12, pages 1595-1603.
Crossref
C. A. M. Stedman & M. L. Barclay. (2001) Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics 14:8, pages 963-978.
Crossref
Katz, Hatlebakk & Castell. (2001) Gastric acidity and acid breakthrough with twice‐daily omeprazole or lansoprazole. Alimentary Pharmacology & Therapeutics 14:6, pages 709-714.
Crossref
D. Y. Graham. 2000. Helicobacter pylori. Helicobacter pylori 453 459 .
Romuald J. Adamek, Christian Szymanski & Boris Pfaffenbach. (2001) Pantoprazole Suppresses Helicobacter pylori Without Affecting Cure . Helicobacter 4:4, pages 266-271.
Crossref
Savarino & Mela. (2001) Letters to Editors. Alimentary Pharmacology & Therapeutics 13:7, pages 977-978.
Crossref
Hiroto Miwa, Akihito Nagahara, Kenji Sato, Ryuichi Ohkura, Toshio Murai, Hidetake Shimizu, Sumio Watanabe & Nobuhiro Sato. (2002) Efficacy of 1 week omeprazole or lansoprazole- amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population. Journal of Gastroenterology and Hepatology 14:4, pages 317-321.
Crossref
Vincenzo Savarino, Giuseppe Sandro Mela & Sergio Vigneri. (1999) Nocturnal Acid Breakthrough in Subjects Taking PPI b.i.d.. The American Journal of Gastroenterology 94:2, pages 536-536.
Crossref
Hiroto Miwa, Ryuichi Ohkura, Toshio Murai, Akihito Nagahara, Toshio Yamada, Tatsuo Ogihara, Sumio Watanabe & Nobuhiro Sato. (1998) Effectiveness of Omeprazole-Amoxicillin-Clarithromycin (OAC) Therapy for Helicobacter pylori Infection in a Japanese Population . Helicobacter 3:2, pages 132-138.
Crossref
Tommy Andersson, Johan Holmberg, Kerstin Röhss & Anders Walan. (2003) Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole. British Journal of Clinical Pharmacology 45:4, pages 369-375.
Crossref
Geus, Mulder, Nicolai, D. M. Van Den Boomgaard & Lamers. (2001) Acid‐inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori ‐negative healthy subjects . Alimentary Pharmacology & Therapeutics 12:4, pages 329-335.
Crossref
Per M. KlevelandHelge L. WaldumEiliv BrennaSteinar AaseJohan A. Mæland. (2008) Relationship Between the Eff icacy of Amoxicillin and Intragastric pH for the Treatment of Helicobacter pylori Infection . Helicobacter 2:3, pages 144-148.
Crossref
Anthony E. Zimmermann & Brian G. Katona. (2012) Lansoprazole: A Comprehensive Review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 17:2, pages 308-326.
Crossref
STUART L HAZELL, GEORGE DASKALOPOULOUS, HAZEL M MITCHELL & DAN MASSEY. (2008) Lansoprazole and amoxycillin: Observations on the treatment of Helicobacter pylori infection . Journal of Gastroenterology and Hepatology 12:2, pages 93-99.
Crossref
Tore Lind, Sander Veldhuyzen van Zanten, Peter Unge, Robin Spiller, Ekkehard Bayerdörffer, Colm O'Morain, Karna Dev Bardhan, Marc Bradette, Naoki Chiba, Michael Wrangstadh, Christer Cederberg & Jan‐Peter Idström. (2007) Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study. Helicobacter 1:3, pages 138-144.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.